Search results
FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV
Morningstar· 1 week ago(Nasdaq: GILD) today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety
Gilead expands FDA label for Biktarvy with Phase I pregnant HIV patient data
Clinical Trials Arena via Yahoo Finance· 6 days agoThe expanded approval of Gilead’s Biktarvy was based on the Phase I trial data showing efficacy in...
FDA Approves Label Update for Gilead’s Biktarvy to Include Pregnant Adults With HIV
Pharmaceutical Executive Magazine· 1 week agoThe FDA based the regulatory action on results from Study 5310, a Phase 1b, open-label, single-arm,...
How 'vampire facials' infected three women with HIV
BBC via Yahoo News· 5 days agoBotulism is a serious illness with symptoms including blurred vision, difficulty swallowing and breathing, slurred speech and fatigue. Botox injection is...
Here’s why ImmunityBio (IBRX) stock price surged and what next | Invezz
Invezz· 2 weeks agoThis rally makes ImmunityBio one of the best-performing stocks in Wall Street as it has risen by...
Gilead (GILD) Gears Up to Report Q1 Earnings: What to Expect?
Zacks· 2 weeks agoFree Report) is set to report first-quarter 2024 results on Apr 25, after market close. In the last reported quarter, the company posted an earnings surprise of -2.27%. Gilead has a market-leading ...
'Vampire Facials' Linked to Cases of HIV. Here's What to Know About the Procedure.
MedPage Today· 5 days agoWhat Is a Vampire Facial? Vampire facials, formally known as platelet-rich plasma microneedling...
Three women likely contracted HIV from 'vampire facials' at closed New Mexico Spa: CDC
USA Today· 1 week agoAccording to the DOH at the time, customers who received "injection-related service,” including a...
Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 1 week agoOnce again, sales growth for the quarter reflected the diversity of our portfolio. HIV product sales...
To save lives, the FDA must change how it evaluates rare disease treatments
Salon.com· 4 days agoFor some conditions, few approved treatments exist. Without accelerated approval, the FDA is failing...